Delivery Order SPE2DB20D1100-SPE2DB25FC4D0
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.96 firm-fixed-price contract is for the supply of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a medication used for diabetes management. The contract has a period of performance through March 5, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a $2,505.41 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide Lyumjev 100 unit/mL KwikPen 3mL, a prescription insulin product. The contract has a firm fixed price and a completion date of April 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award, valued at $3,334.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price of $1,013.45 and a completion date of February 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,773.57, is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 5, 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,315.66 firm fixed price delivery order to provide LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYUMJEV 100 UNIT/ML VIAL 10ML. The contract, which has a firm fixed price of $1,032.09 and a period of performance through August 8, 2024, was not set aside for any specific business category. As a key supplier to various federal agencies, AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyumjev 100 Unit/mL KwikPen 3mL medication. The total ceiling value of the contract is $2,419.47, and it is structured as a Firm Fixed Price Delivery Order, with a period of performance through September 9, 2024. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office Division, has been...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,116.13 firm fixed-price delivery order is for the supply of LYUMJEV 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a period of performance through April 23, 2024. Amerisourcebergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,060 to Amerisourcebergen Drug Corporation to supply 100 unit/mL KwikPen 3mL LYUMJEV insulin for treatment of diabetes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 3, 2023 in support of the Agency's medical readiness and logistics programs. No subcontractors or set aside designations were indicated. The...